U.S. Healthcare Services Stock News

NYSE:EL
NYSE:ELPersonal Products

Is Estée Lauder (EL) Reframing Its Growth Story Around Emerging Markets And Digital Channels?

Earlier this year, Estée Lauder Companies’ CEO and a regional President spoke at the Morgan Stanley Luxury Conference 2026 in Paris, with the discussion made available via live and archived webcast for investors and other stakeholders. The conference appearance gave management a high-profile stage to articulate its thinking on emerging markets expansion and digital channels, areas already central to the company’s growth story. Next, we’ll examine how this executive appearance, particularly...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

How Softer Q1 Earnings and Steady Dividend Policy Could Shape Power Integrations’ (POWI) Investment Story

Earlier in May 2026, Power Integrations, Inc. reported first-quarter 2026 results showing sales of US$108.31 million and net income of US$3.3 million, while also declaring a quarterly dividend of US$0.215 per share payable on June 30, 2026 to shareholders of record on May 29, 2026. The combination of modest year-on-year sales growth, lower earnings, and continued dividend payments gives investors a clearer picture of how Power Integrations is balancing profitability pressures with ongoing...
NYSE:TDC
NYSE:TDCSoftware

Is Teradata (TDC) Still Attractively Priced After Strong One Year Share Price Rebound?

Wondering if Teradata at around US$32.65 is pricing in too much optimism or still offering value? This article walks through what the current numbers might be telling you. The stock has returned 2.9% over the past week, 20.5% over the past month, 10.0% year to date and 45.2% over the past year, while longer periods show declines of 27.0% over three years and 29.9% over five years. Recent headlines have focused on Teradata's role as a data and analytics platform provider, with attention on...
NYSE:POR
NYSE:PORElectric Utilities

Is It Too Late To Consider Portland General Electric (POR) After A 20% One-Year Gain?

Investors may be wondering whether Portland General Electric at around US$49.29 is offering good value right now, or if the recent gains have already been priced in. The stock is up 1.8% over the last week, has fallen 6.0% over the last month, and sits on a 20.5% return over the past year, which may signal shifting expectations around both its potential and its risks. Recent coverage around Portland General Electric has focused on its role as a regulated electric utility and how it fits into...
NYSE:FOUR
NYSE:FOURDiversified Financial

Assessing Shift4 Payments (FOUR) Valuation After First Quarter Results And Growing SkyTab Adoption

Shift4 Payments (FOUR) is back in focus after its first quarter update, where management highlighted broad-based revenue growth, resilient operations despite travel disruptions, and increasing adoption of its payment solutions, including SkyTab and international offerings. See our latest analysis for Shift4 Payments. Despite the earnings update and new crypto partnership with Lydian, Shift4 Payments’ share price has fallen 17.46% over the past 30 days and 34.60% year to date, while the 1 year...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Does Columbia Banking System’s (COLB) Steady Dividend Signal Capital Discipline or Limited Reinvestment Ambition?

Columbia Banking System, Inc. recently declared a quarterly cash dividend of US$0.37 per common share, payable on June 15, 2026, to shareholders of record as of May 29, 2026. This latest payout extends the bank’s long record of regular cash distributions, underscoring its emphasis on shareholder returns even as it works through profitability challenges. With this confirmed US$0.37 quarterly dividend in place, we’ll now consider how the payout shapes Columbia Banking System’s broader...
NYSE:MRSH
NYSE:MRSHInsurance

Is It Time To Reconsider Marsh & McLennan Companies (MRSH) After A 27% One-Year Share Price Fall

If you are wondering whether Marsh & McLennan Companies, at around US$166 per share, still offers solid value, it helps to step back and look at what the current price might be implying. The stock is up 1.6% over the last 7 days, but is down 5.5% over 30 days, down 9.0% year to date, and has fallen 26.7% over the past year, which may have shifted how the market is thinking about its risk and return profile. Recent attention on the broader insurance and risk management sector has kept Marsh &...
NasdaqGS:INBX
NasdaqGS:INBXBiotechs

A Look At Inhibrx Biosciences (INBX) Valuation After HexAgon Phase 2 Data And Phase 3 Plans

Inhibrx Biosciences (INBX) has become a focus for biotech investors after reporting interim Phase 2 HexAgon data on INBRX-106 combined with pembrolizumab in first-line head and neck cancer, alongside a recent first quarter earnings update. See our latest analysis for Inhibrx Biosciences. The interim HexAgon data and first quarter earnings update come after a period of strong market interest, with a 30 day share price return of 24.12% and a year to date share price return of 45.94%. The 1 year...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Waystar Holding Approves US$200m Buyback As Shares Trade Below Targets

Waystar Holding's Board of Directors has authorized a $200 million stock repurchase plan. The buyback approval covers shares of NasdaqGS:WAY at a current share price of $19.6. The program signals an intention to return capital to shareholders through share repurchases. For investors watching NasdaqGS:WAY, the new $200 million buyback plan comes after a challenging period for the stock. The share price is $19.6, with the stock down 24.0% over the past 30 days, down 37.5% year to date, and...
NasdaqGS:IOSP
NasdaqGS:IOSPChemicals

Assessing Innospec (IOSP) Valuation After New US$75 Million Buyback And Higher Dividend

Innospec (IOSP) has announced a new US$75 million share repurchase authorization along with a 10% increase in its semi-annual dividend, placing capital returns at the center of the current story for the stock. See our latest analysis for Innospec. The buyback and dividend increase come after a mixed period for Innospec, with the share price falling 11% over the past three months and the 1 year total shareholder return down 12%, suggesting sentiment has been cooling despite recent capital...
NYSE:AMC
NYSE:AMCEntertainment

AMC Shares Rally After CEO Share Purchase While Fathom Adds Bad Counselors Release

AMC Entertainment Holdings (NYSE:AMC) is planning a nationwide theatrical release of the comedy film "Bad Counselors" through its Fathom Entertainment division. The release is scheduled for July 2026 and focuses on specialty content distribution beyond traditional studio movies. The move highlights AMC's push to use Fathom Entertainment as a platform for alternative programming that sits alongside regular Hollywood titles. For investors tracking NYSE:AMC, this specialty release arrives...
NYSE:GIC
NYSE:GICTrade Distributors

A Look At Global Industrial (GIC) Valuation After Better Than Expected Q1 Results

Why Global Industrial’s Q1 Beat Matters for Investors Global Industrial (GIC) reported Q1 revenue 9.2% higher year over year, with adjusted operating income above analyst estimates. Despite this, the stock is down about 12% since the release and trades near $28.92. This combination of headline strength and softer profitability, driven by higher marketing, compensation, fuel surcharges, and tariffs, leaves investors weighing how much value to place on the current growth across core accounts...
NYSE:BIO
NYSE:BIOLife Sciences

Elliott Stake Puts Bio-Rad Turnaround Plans And Sartorius Holding In Focus

Elliott Investment Management has built a significant stake in Bio-Rad Laboratories (NYSE:BIO). The activist position signals potential pressure for changes in operations, governance, or portfolio structure. This development comes as Bio-Rad’s shares trade at $281.05 and the company holds a sizable stake in Sartorius. For investors tracking NYSE:BIO, Elliott’s move lands on top of a mixed share price record, with the stock up 16.3% over the past week and 13.8% over the past year, but down...
NasdaqCM:HOVR
NasdaqCM:HOVRAerospace & Defense

Assessing New Horizon Aircraft (HOVR) Valuation After New Equity Raise And Hybrid Electric VTOL Updates

Why New Horizon Aircraft’s latest equity raise matters for investors New Horizon Aircraft (NasdaqCM:HOVR) has just completed a registered direct follow on equity offering of about US$19.9 million, selling 9,254,889 Class A ordinary shares at US$2.15, a US$0.1505 discount per share. This capital raise, alongside recent calls outlining plans for its hybrid electric vertical takeoff and landing platform, puts fresh attention on how the company intends to fund development while managing dilution...
NasdaqGS:IRTC
NasdaqGS:IRTCMedical Equipment

What iRhythm Holdings (IRTC)'s Sustained Zio Growth and 2027 AI Launch Plan Means For Shareholders

iRhythm Holdings recently reported its sixth consecutive quarter of over 20% growth, driven by its core Zio Monitor business, alongside improving profitability supported by automation and operating scale. The company also reaffirmed plans to launch its AI-enabled Zio MCT offering in the first half of 2027, underscoring its focus on efficiency and cost savings. We’ll now explore how iRhythm’s sustained growth and AI-enabled product roadmap may influence the company’s existing investment...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Does Alvotech’s (ALVO) FDA Inspection Outcome Reframe Confidence in Its Biosimilar Strategy for 2026?

Earlier in May 2026, Alvotech reported that the FDA completed a routine cGMP surveillance inspection of its Reykjavik manufacturing facility, issuing a Form 483 that the company believes involves addressable observations and supports resubmission of key Biologics License Applications this quarter. Management is framing the inspection outcome as validation of the site’s quality improvements and as support for its expectation of FDA decisions on the relevant BLAs during 2026, a crucial pillar...
NasdaqGS:PATK
NasdaqGS:PATKAuto Components

Patrick Industries Renews Board As Dividends And Buybacks Face Cyclical Tests

Patrick Industries (NasdaqGS:PATK) held its annual shareholder meeting, electing a new board of directors and ratifying its auditor. Shareholders approved the latest executive compensation package. The company reaffirmed its focus on shareholder returns with a newly declared dividend and recent share buybacks. Patrick Industries enters this period of corporate housekeeping with its stock at $88.79 and a mixed recent track record. The share price is down 5.9% over the past week, down 17.0%...
NYSE:REZI
NYSE:REZIBuilding

Assessing Resideo Technologies (REZI) Valuation After A Sharp Pullback And ADI Separation Plans

Resideo Technologies (REZI) has been drawing fresh attention after recent share price moves, with the stock down 27% over the past week and about 33% lower over the past month. See our latest analysis for Resideo Technologies. Zooming out, the recent share price drop sits alongside a weaker short term trend, with the stock down over the past quarter, while the 1 year total shareholder return remains positive and suggests earlier gains are being reassessed. If sharp moves in home and building...
NYSE:DLR
NYSE:DLRSpecialized REITs

Is It Too Late To Reassess Digital Realty Trust (DLR) After This Year’s 20% Rally?

Investors may be wondering if Digital Realty Trust at about US$186 per share still offers value, or if most of the upside has already been priced in. The stock is up 20.2% year to date and 12.7% over the past year, even though it has fallen 4.6% over the last week and 8.5% over the last month. These moves can change how investors think about its risk and reward trade off. Recent attention on data center operators tied to artificial intelligence, along with ongoing discussion around funding...
NYSE:GGG
NYSE:GGGMachinery

Is Graco (GGG) Offering An Opportunity After Recent Share Price Weakness?

If you are wondering whether Graco's current share price lines up with its underlying value, this breakdown will help you connect the dots before you commit new capital. Graco's stock recently closed at US$75.32, with the share price down 2.3% over the past week, 13.2% over the last month and 12.0% over the past year, while edging up 1.6% over three years and 6.8% over five years. Recent coverage around Graco has focused on its position in the capital goods space and investor interest in how...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold Leans Into Royalty Model With Hod Maden Restructuring

Royal Gold restructured its interest in the Hod Maden Project, exchanging its direct ownership stake for a 2.5% net smelter return royalty. The transaction involved selling part of its equity stake to project partner Lidya Mines while retaining exposure through future royalty payments. This move reduces Royal Gold's exposure to project capital and operating costs and increases its focus on royalty based income. Royal Gold, ticker NasdaqGS:RGLD, recently experienced mixed share price...
NasdaqGS:EXPO
NasdaqGS:EXPOProfessional Services

A Look At Exponent (EXPO) Valuation After Strong Q1 Earnings And Recent Share Price Declines

Exponent (EXPO) is back in focus after its latest quarter, where revenue grew 10.5% year on year and topped forecasts by 1.8%, while earnings per share fell short and raised questions about profitability. See our latest analysis for Exponent. Since that earnings release, the stock’s 30 day share price return is down 16.25% and the year to date share price return is down 18.76%, while the 1 year total shareholder return has declined 26.98%. This points to fading momentum as investors reassess...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

Synaptics (SYNA) Valuation Check After Google I/O Edge AI Showcase And COMPUTEX Attention

Synaptics (SYNA) has attracted fresh attention after its Coralboard Edge AI platform, built with Google Research, featured at Google I/O 2026. This highlighted the company’s role in on-device AI and upcoming COMPUTEX Taipei presentations. See our latest analysis for Synaptics. Recent events around Coralboard at Google I/O and Synaptics’ COMPUTEX plans have coincided with a 54.13% 1 month share price return and a 90.22% 1 year total shareholder return, suggesting strong momentum built over...